Table 2. Patient's distribution by FAB classification and mutation analysis.
N | % | Total | |
---|---|---|---|
FAB classification | 43 | ||
M1 | 7 | 16.3 | |
M2 | 14 | 32.5 | |
M5 | 22 | 51.2 | |
Mutation analysis | Analyzed (N, % of total) (37, 86%) | ||
NPM1 | 3 | 8.1 | |
FLT3-ITD | 2 | 5.4 |
FAB, French-American-British; NPM1, nucleophosmin; FLT3-ITD, FMS-Like Receptor Tyrosine Kinase-3 Internal Tandem Duplication